Edick Paul R

Track

Insider profile

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 85% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Edick Paul R's trades of Xeris Biopharma Holdings Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
320.83
Quantity 28,323 -49.8%
Value US$1,615,382
Transaction date
Sale
Price
2.65
Quantity 10,931
Value £28,967
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-09 2023-08-09
B Purchase
26,645 +12.3%
406.29
US$2,364,306 		26,645 +12.3% 406.29 US$2,364,306
2022-12-14 2022-12-13
B Purchase
28,323 -49.8%
320.83
US$1,615,382 		28,323 -49.8% 320.83 US$1,615,382
2022-05-13 2022-05-12
B Purchase
55,092 -5.4%
325.27
US$1,529,757 		55,092 -5.4% 325.27 US$1,529,757
2021-11-16 2021-11-15
B Purchase
20,000 +148.9%
2.28
US$45,664 		20,000 +148.9% 2.28 US$45,664
2021-11-12 2021-11-11
B Purchase
200,000 +32.9%
2.08
US$415,760 		200,000 +32.9% 2.08 US$415,760
2021-09-14 2021-09-10
S Sale
10,931
2.65
£28,967 		10,931 2.65 £28,967
2020-12-10 2020-12-09
B Purchase
10,000 +2.5%
4.06
US$40,551 		10,000 +2.5% 4.06 US$40,551
2020-05-11 2020-05-08
B Purchase
33,000 +9.0%
3.00
US$99,000 		33,000 +9.0% 3.00 US$99,000
2020-02-18 2020-02-14
B Purchase
20,000 +12.3%
4.15
US$83,000 		20,000 +12.3% 4.15 US$83,000
2019-11-27 2019-11-25
B Purchase
17,935 +11.6%
8.55
US$153,283 		17,935 +11.6% 8.55 US$153,283
2019-03-12 2019-03-11
B Purchase
30,000 +24.0%
9.12
US$273,585 		30,000 +24.0% 9.12 US$273,585